七宝美髯汤内服与梅花针叩刺联合西药治疗斑秃临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R275;R758.71

基金项目:

广东省中医药局资助项目(20201370)


Clinical Study on Oral Administration of Qibao Meiran Tang and Tapping by Plum- Blossom Needle Combined with Western Medicine for Alopecia Areata
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察在西药基础上加用七宝美髯汤内服与梅花针叩刺治疗斑秃的疗效及对患者免疫功能的影响。方法:选择50 例斑秃患者作为研究对象,采用随机数字表法分为观察组及对照组各25 例。2 组均以米诺地尔酊、丙酸氟替卡松乳膏涂抹脱发区,口服复方甘草酸苷片治疗,观察组加用七宝美髯汤加减方内服联合梅花针叩刺治疗。2 组均治疗8 周。于治疗前与治疗8 周后评定中医证候评分、脱发面积严重程度工具(SALT)评分,检测CD3+、CD4+、CD8+水平、CD4+/CD8+比值及干扰素-γ(IFN-γ)、白细胞介素-10(IL-10)、白细胞介素-17(IL-17) 水平,采用皮肤病生活质量指数(DLQI) 评估过去1 周斑秃对患者生活造成的影响,并观察治疗期间患者的不良反应及不良事件以评价治疗的安全性。比较2 组的临床疗效。结果:治疗8 周后,观察组愈显率为76.00%,高于对照组的48.00%,2 组比较,差异有统计学意义(P<0.05)。2 组中医证候积分、SALT 评分、DLQI 评分及IFN-γ、IL-17 水平均较治疗前下降(P<0.01,P<0.05),观察组以上5 项指标比值均低于对照组(P<0.01,P<0.05)。2 组CD3+、CD4+水平及CD4+/CD8+比值均较治疗前升高(P<0.05),观察组CD3+、CD4+水平及CD4+/CD8+比值均高于对照组(P<0.01,P<0.05)。2 组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:在常规西药基础上加用内服七宝美髯汤加减方联合梅花针叩刺治疗斑秃,可有效改善患者的免疫功能,减轻症状,促进头发生长,提高患者的生活质量,对免疫功能的影响是联合疗法治疗斑秃的可能机制。

    Abstract:

    Abstract:Objective:To observe the curative effect of the oral administration of Qibao Meiran tang and tapping by plumblossom needle based on western medicine on alopecia areata, and its effect on immune function. Methods: A total of 50 cases of patients with alopecia areata were selected as the study objects,and were divided into the observation group and the control group according to the random number table method,25 cases in each group. In the two groups,hair loss area was coated with minoxidil and fluticasone propionate cream, and both groups were given the oral administration of compound glycyrrhizin tablets. The observation group was additionally given oral administration of modified Qibao Meiran tang combined with tapping by plum-blossom needle. Both groups were treated for eight weeks. Before treatment as well as after eight- week treatment, Chinese medicine syndrome score and the score of severity of alopecia tool(SALT) were evaluated. Levels of CD3 +,CD4 +,CD8 +,CD4 +/CD8 +,interferon-γ(IFN-γ),interleukin- 10(IL- 10),and interleukin- 17(IL- 17) were detected. The Dermatology Life Questionnaire Index(DLQI) was used to evaluate the effect of alopecia areata on life of patients during the past week. Adverse reactions and event during treatment were observed so as to evaluate medication safety. The clinical effect was compared between the two groups. Results: After eight- week treatment, the cured and markedly effective rate was 76.00% in the observation group,higher than that of 48.00% in the control group,the difference being significant(P<0.05). The scores of Chinese medicine syndrome,SALT,DLQI and the levels of IFN-γ and IL-17 in the two groups were decreased when compared with those before treatment(P<0.01,P<0.05),and the above five indexes in the observation group were lower than that in the control group, the difference being significant(P<0.01, P<0.05).The levels of CD3+,CD4+,and CD4+/CD8+ in the two groups were increased when compared with those before treatment(P< 0.05),and the three levels in the observation group were higher than those in the control group(P<0.01,P<0.05). There was no significant difference being found in the comparison of the incidence of adverse reactions between the two groups(P> 0.05). Conclusion:Based on routine western medicine,the additional therapy of oral administration of Qibao Meiran tang and tapping by plum-blossom needle has a good clinical effect in the treatment of patients with alopecia areata. It can effectively improve the patients' immune function, relieve symptoms, promote hair growth, and enhance their quality of life. Its possible mechanism involves the effect on immune function in the treatment of alopecia areata.

    参考文献
    相似文献
    引证文献
引用本文

王升强,陈霞,彭晓燕,陈霭平.七宝美髯汤内服与梅花针叩刺联合西药治疗斑秃临床研究[J].新中医,2021,53(14):40-45

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-07-24
  • 出版日期: